FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4066511000001101: Neomycin 0.5% / Betamethasone 0.1% eye ointment 3 gram (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21891901000001114 Neomycin 0.5% / Betamethasone 0.1% eye ointment 3 gram (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21892001000001118 Neomycin 0.5% / Betamethasone 0.1% eye ointment 3 gram en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Neomycin 0.5% / Betamethasone 0.1% eye ointment 3 gram Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Neomycin 0.5% / Betamethasone 0.1% eye ointment 3 gram Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Neomycin 0.5% / Betamethasone 0.1% eye ointment 3 gram Is pack of Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment false Inferred relationship Existential restriction modifier
Neomycin 0.5% / Betamethasone 0.1% eye ointment 3 gram Has active ingredient Neomycin sulfate false Inferred relationship Existential restriction modifier
Neomycin 0.5% / Betamethasone 0.1% eye ointment 3 gram Has active ingredient Betamethasone sodium phosphate false Inferred relationship Existential restriction modifier
Neomycin 0.5% / Betamethasone 0.1% eye ointment 3 gram Has active ingredient Skin anti-infective false Inferred relationship Existential restriction modifier
Neomycin 0.5% / Betamethasone 0.1% eye ointment 3 gram VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Neomycin 0.5% / Betamethasone 0.1% eye ointment 3 gram VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Neomycin 0.5% / Betamethasone 0.1% eye ointment 3 gram Has manufactured dose form Ointment false Inferred relationship Existential restriction modifier
Neomycin 0.5% / Betamethasone 0.1% eye ointment 3 gram Has VMP Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment true Inferred relationship Existential restriction modifier
Neomycin 0.5% / Betamethasone 0.1% eye ointment 3 gram Has specific active ingredient Neomycin sulfate true Inferred relationship Existential restriction modifier
Neomycin 0.5% / Betamethasone 0.1% eye ointment 3 gram Has specific active ingredient Betamethasone sodium phosphate true Inferred relationship Existential restriction modifier
Neomycin 0.5% / Betamethasone 0.1% eye ointment 3 gram Has dispensed dose form Ointment false Inferred relationship Existential restriction modifier
Neomycin 0.5% / Betamethasone 0.1% eye ointment 3 gram Has dispensed dose form Conventional release eye ointment true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Betnesol-N eye ointment (Celltech Pharmaceuticals Ltd) 3 gram Is a True Neomycin 0.5% / Betamethasone 0.1% eye ointment 3 gram Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start